GENEVA, Feb. 2 -- ELANCO ANIMAL HEALTH GMBH (Alfred-Nobel Strasse 5040789 Monheim am Rhein) filed a patent application (PCT/EP2025/071506) for "MAMMALIAN IL-4/IL-13/FLAGELLIN CONSTRUCTS" on Jul 25, 2025. With publication no. WO/2026/022365, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ILG, Thomas (Laacher Weg 3340667 Meerbusch)
Abstract: The present disclosure relates to IL-13/IL-4/Flagellin fusion proteins for the stimulation of the production of anti-IL-4 and anti-IL13 antibodies in a non-human mammal, in particular...